Learn the differences between asthma, acute and chronic bronchitis, their symptoms, and treatments. Get insights on managing overlapping symptoms of these lung conditions.

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease: London, UK Saturday, February 7, 2026, 09:00 Hrs [IST] GSK plc announced the E ...

Pennsylvania officials push back against federal plans to eliminate the scientific declaration that greenhouse gases endanger ...

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstructive pulmonary disease.

GSK announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults in the EU with uncontrolled COPD characterised by raised blood eosinophils ...

Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

In a synopsis of a clinical practice guideline issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Feb. 17 in the Annals of Internal Medicine, updated ...

Children exposed to high levels of fine particulate matter and water damage/home dampness in their early life had a ...

This month, the U.S. Environmental Protection Agency (EPA) finalized its repeal of the Endangerment Finding, the agency’s ...

Winter Olympians face a number of challenges as they chase Olympic gold. But one of their greatest opponents, that is rarely ...

Asthma affects millions of people worldwide, and adult women experience the condition more frequently—and often more severely—than men. Symptoms can also fluctuate during puberty, pregnancy and ...